A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples